In the News

In this article, Jeffrey James, EVP Alliance Management, offers his insights on what it takes to be a trusted partner to sponsors in the clinical development industry.

Using real-world evidence, this article shows how vaccines benefit healthcare systems through cost-effectiveness models.

In this article, Dr Andrew Garrett, Executive Vice President of Scientific Operations, explores the need for interdisciplinary collaboration between pharmaceutical and non-pharmaceutical researchers and public health centres to consider the overlap between NPIs and PIs and identify where standards can be improved and enforced.

This article discusses the importance of disease surveillance, developments in early outbreak detection, and the role of smart data reporting and adaptive trial designs.

This article looks at the CGT landscape, the challenges biopharma companies face in running clinical trials and tips on how to surmount those obstacles.

ICON Language Services Director Patrick Majewski shares the importance of and key considerations in clinical trial translations.

This article outlines the role of digital health technology tools in supporting medical adherence.

Read how our partnership with AWS has allowed us to integrate voice enabled diary collection into trials and how it contributes to a better participant experience.

This article discusses the importance of DEI in rare disease clinical trials and shares actionable points for a more inclusive approach.

The impact of the clinical trial liaison function (CTL) in developing and delivering optimal clinical trials.